Vistagen Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Aug 23 | BuyUS$17,961,079 | Commodore Capital LP | Company | 775,756 | US$23.15 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,298 | 0.0344% |
Individual Insiders | 45,026 | 0.167% |
VC/PE Firms | 4,535,315 | 16.8% |
Institutions | 6,879,910 | 25.5% |
Hedge Funds | 7,181,912 | 26.6% |
General Public | 8,373,748 | 31% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 269.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,676,580 | US$12.9m | 0% | 1.18% | |||
2,000,000 | US$9.7m | 0% | 0.24% | |||
1,858,735 | US$9.0m | 0% | 1.29% | |||
1,834,512 | US$8.9m | 623% | no data | |||
1,816,730 | US$8.8m | 0% | 0.85% | |||
1,790,182 | US$8.6m | 0% | 2.43% | |||
1,575,000 | US$7.6m | 0% | 0.53% | |||
808,550 | US$3.9m | 709% | 0.64% | |||
743,495 | US$3.6m | 8,590% | no data | |||
743,495 | US$3.6m | 1,410% | 0.01% | |||
478,000 | US$2.3m | 0% | 0.06% | |||
346,683 | US$1.7m | 294% | no data | |||
274,472 | US$1.3m | 275% | no data | |||
245,502 | US$1.2m | 0% | 0.48% | |||
192,059 | US$927.7k | 0% | no data | |||
163,788 | US$791.1k | 0% | no data | |||
150,000 | US$724.5k | 50% | 0.5% | |||
126,394 | US$610.5k | 0% | 0.54% | |||
98,000 | US$473.3k | 382% | 0.89% | |||
96,900 | US$468.0k | 0% | no data | |||
88,046 | US$425.3k | 3.37% | no data | |||
58,377 | US$282.0k | 142,000% | no data | |||
54,311 | US$262.3k | 0% | 0.06% | |||
49,508 | US$239.1k | 94.4% | no data | |||
48,839 | US$235.9k | 236% | no data |